Gallardo, Analyn C.
HRN: 02-63-32 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/04/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/04/2024
08/04/2024
IV
375mg
Loading Dose
T/c Urosepsis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes